跳至主要内容
临床试验/NL-OMON38669
NL-OMON38669已完成不适用

Glycosylation Defects causing DYslipidemia - GiDDY

Academisch Medisch Centrum0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Included are all healthy heterozygous carriers and non-affected family members of patients diagnosed with congenital disorder of glycosylation, aged 18 or older. Healthy individuals will be included as a control population.

排除标准

  • - Known systemic disorders such as hepatic, renal, hematologic, and malignant
  • diseases or any clinically significant medical condition that could interfere with the
  • conduct of the study in the opinion of the investigator.
  • - Standard contra-indications to MRI based on physicians experience and current practices
  • - Claustrophobia
  • - Metal in the body, as a result of e.g. osteosynthetic material, pacemaker
  • implantation or artificial cardiac valves.
  • - Inability or unwillingness to comply with the protocol requirements.;When dyslipidemia is present, exclusion criteria are all secondary causes of dyslipidemia (nephrotic syndrome, adrenal insufficiency, renal insufficiency, hypothyroidism, heavy alcohol use, cholestasis, use of protease inhibitors).

研究者

相似试验

Glycosylation Defects causing DYslipidemia | 临床试验